Ann: 2018 Annual Report, page-33

This was a good find from Chookboy so I thought I'd copy on this thread as well. Does anyone else have any updated broker ratings or reports?

FY18 results were in line with guidance. Morgans notes there was no update on the timing of class action cases and the company expects continued modest improvement in FY19 operating earnings.
Shine did call out the Pelvic Mesh class action as a key driver of FY18 revenue. Add rating maintained. Target rises to $1.27 from $1.09.
Sector: Consumer Services.
Target price is $1.27.Current Price is $0.94. Difference: $0.33 - (brackets indicate current price is over target). If SHJ meets the Morgans target it will return approximately 26% (excluding dividends, fees and charges - negative figures indicate an expected loss).